Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-associated graft-versus-host disease.

Ozgur Akin Oto1, Semra Paydas, Fikri Baslamisli

  • 1Department of Internal Medicine, Cukurova University Faculty of Medicine, Adna, Turkey.

European Journal of Internal Medicine
|April 19, 2006
PubMed
Summary

Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare but fatal condition. Prevention through blood product irradiation and avoiding family donors is essential, as treatment options are limited.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician-patient survey.

Scientific reports·2026
Same author

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

International journal of cancer·2026
Same author

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.

Clinical genitourinary cancer·2026
Same author

Clinicopathologic features and outcomes of patients with DNAJB9-positive fibrillary glomerulonephritis.

Clinical kidney journal·2026

Area of Science:

  • Hematology
  • Immunology
  • Transfusion Medicine

Background:

  • Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare but severe complication of blood transfusions.
  • It carries a high mortality rate, often exceeding 90%, despite various therapeutic interventions.
  • Non-specific clinical signs and symptoms can lead to diagnostic challenges and delays.

Purpose of the Study:

  • To highlight the diagnostic importance of transfusion history in suspected TA-GVHD cases.
  • To emphasize the critical role of prophylaxis in preventing TA-GVHD.
  • To review diagnostic criteria and management strategies for TA-GVHD.

Main Methods:

  • Case series evaluation of four patients with suspected TA-GVHD.
  • Comprehensive literature review on TA-GVHD pathophysiology, diagnosis, and treatment.

Related Experiment Videos

  • Differential diagnosis considerations for patients presenting with fever, rash, diarrhea, pancytopenia, icterus, and renal failure.

    • Main Results:

    • Transfusion history was a crucial diagnostic element.
    • Skin biopsy confirmed TA-GVHD in evaluated patients.
    • Differential diagnosis was essential to rule out other conditions with similar presentations.

    Conclusions:

    • TA-GVHD should be strongly considered in patients with characteristic symptoms and a relevant transfusion history.
    • Prophylaxis, including blood product irradiation and avoidance of allogeneic family donations, is paramount due to high mortality.
    • Early recognition and preventative measures are key to managing TA-GVHD effectively.